Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma

Abstract Background Intractable nasopharyngeal hemorrhage is a severe complication with high mortality rate in patients with radiation therapy (RT) for nasopharyngeal carcinoma (NPC) that requires emergency treatment. Quite a few of them combine with tumor recurrence. Treatment planning for these pa...

Full description

Bibliographic Details
Main Authors: Bao‐Feng Duan, Hua‐Ying Chen, Xue‐Mei Zheng, Qing He
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.1671
_version_ 1828344101744934912
author Bao‐Feng Duan
Hua‐Ying Chen
Xue‐Mei Zheng
Qing He
author_facet Bao‐Feng Duan
Hua‐Ying Chen
Xue‐Mei Zheng
Qing He
author_sort Bao‐Feng Duan
collection DOAJ
description Abstract Background Intractable nasopharyngeal hemorrhage is a severe complication with high mortality rate in patients with radiation therapy (RT) for nasopharyngeal carcinoma (NPC) that requires emergency treatment. Quite a few of them combine with tumor recurrence. Treatment planning for these patients is extremely difficult for oncologists, and effective treatments are lacking. Case A 42‐year‐old man had a history of recurrent NPC that was treated with 2 cycles of chemoradiotherapies from 2017 to 2019. Five months after the second round of chemoradiotherapy, an episode of massive nasal bleeding occurred. As positron emission tomography (PET) scan revealed tumor recurrence in the left wall of nasopharynx, superselective embolization and subsequent intra‐arterial infusion (IA, 4 times of cisplatin 60 mg + fluorouracil 1.0 g) were performed to stop bleeding and achieve tumor control. To date, the disease‐free survival time has been over 1 year. No tumor recurrence or rebleeding is found except for alopecia on the left side. Conclusions Interventional radiology is important and effective in the treatment of recurrent NPC for both massive nasal bleeding and tumor control. However, the unique complication of unilateral alopecia should not be ignored.
first_indexed 2024-04-13T23:52:32Z
format Article
id doaj.art-37e0733d8ec346f595479d0c23aedc84
institution Directory Open Access Journal
issn 2573-8348
language English
last_indexed 2024-04-13T23:52:32Z
publishDate 2022-10-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj.art-37e0733d8ec346f595479d0c23aedc842022-12-22T02:24:01ZengWileyCancer Reports2573-83482022-10-01510n/an/a10.1002/cnr2.1671Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinomaBao‐Feng Duan0Hua‐Ying Chen1Xue‐Mei Zheng2Qing He3Department of Head and Neck Oncology West China Hospital of Sichuan University Chengdu Sichuan Province ChinaDepartment of Head and Neck Oncology West China Hospital of Sichuan University Chengdu Sichuan Province ChinaDepartment of Head and Neck Oncology West China Hospital of Sichuan University Chengdu Sichuan Province ChinaDepartment of Head and Neck Oncology West China Hospital of Sichuan University Chengdu Sichuan Province ChinaAbstract Background Intractable nasopharyngeal hemorrhage is a severe complication with high mortality rate in patients with radiation therapy (RT) for nasopharyngeal carcinoma (NPC) that requires emergency treatment. Quite a few of them combine with tumor recurrence. Treatment planning for these patients is extremely difficult for oncologists, and effective treatments are lacking. Case A 42‐year‐old man had a history of recurrent NPC that was treated with 2 cycles of chemoradiotherapies from 2017 to 2019. Five months after the second round of chemoradiotherapy, an episode of massive nasal bleeding occurred. As positron emission tomography (PET) scan revealed tumor recurrence in the left wall of nasopharynx, superselective embolization and subsequent intra‐arterial infusion (IA, 4 times of cisplatin 60 mg + fluorouracil 1.0 g) were performed to stop bleeding and achieve tumor control. To date, the disease‐free survival time has been over 1 year. No tumor recurrence or rebleeding is found except for alopecia on the left side. Conclusions Interventional radiology is important and effective in the treatment of recurrent NPC for both massive nasal bleeding and tumor control. However, the unique complication of unilateral alopecia should not be ignored.https://doi.org/10.1002/cnr2.1671adverse effectsalopeciainterventional radiologynasopharyngeal carcinomaradiation therapy
spellingShingle Bao‐Feng Duan
Hua‐Ying Chen
Xue‐Mei Zheng
Qing He
Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma
Cancer Reports
adverse effects
alopecia
interventional radiology
nasopharyngeal carcinoma
radiation therapy
title Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma
title_full Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma
title_fullStr Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma
title_full_unstemmed Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma
title_short Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma
title_sort acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma
topic adverse effects
alopecia
interventional radiology
nasopharyngeal carcinoma
radiation therapy
url https://doi.org/10.1002/cnr2.1671
work_keys_str_mv AT baofengduan acquiredunilateralalopeciaafterarterialinfusionchemotherapyinarecurrentnasopharyngealcarcinoma
AT huayingchen acquiredunilateralalopeciaafterarterialinfusionchemotherapyinarecurrentnasopharyngealcarcinoma
AT xuemeizheng acquiredunilateralalopeciaafterarterialinfusionchemotherapyinarecurrentnasopharyngealcarcinoma
AT qinghe acquiredunilateralalopeciaafterarterialinfusionchemotherapyinarecurrentnasopharyngealcarcinoma